首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1562408

到 2030 年欧洲肠外营养市场预测 - 区域分析 - 按营养类型和最终用户

Europe Parenteral Nutrition Market Forecast to 2030 - Regional Analysis - by Nutrient Type and End User

出版日期: 2024年07月04日 | 出版商:

The Insight Partners | 英文 90 Pages | 订单完成后即时交付

价格

简介目录图表

2022年欧洲肠外营养市场价值为24.0463亿美元，预计到2030年将达到39.5807亿美元；预计2022年至2030年复合年增长率为6.4%。

营养不良和早产病例激增推动欧洲肠外营养市场

营养不良包括营养不良、超重或肥胖、维生素或矿物质不足，以及因不良饮食而患有非传染性疾病。根据世界卫生组织 (WHO) 的资料，到 2021 年，约 19 亿成年人超重或肥胖，而 4.62 亿人体重不足。中长期缺乏营养丰富的食物，导致4,500 万人被浪费（对于身高而言太瘦）。此外，约 45% 的 5 岁以下儿童死亡与营养不良有关。根据联合国儿童基金会2022年7月的资料，营养不良发生率从2019年的8.0%增加到2020年的9.3%； 2021年进一步跃升至9.8%。

根据欧洲专业营养研究，2019 年欧洲约 40% 的住院成人患者营养不良。英国的医院和家庭护理机构遭受营养不良。根据需要透过肠外方法提供营养支持是治疗大多数营养不良病例的重要且适当的方法。

早产是指婴儿在非常早期的阶段出生，也就是在怀孕37週之前出生。根据世界卫生组织 2023 年发布的资料，2020 年全球报告了约1,340 万早产（超过十分之一）。 %。大量早产儿体重过轻，免疫力不发达，导致他们的生命处于危险之中。早产儿优选肠外营养，因为吸吮或吞嚥困难是未成熟分娩的併发症，或是神经肌肉、心臟或其他疾病所致。当出生后无法透过肠内途径安全满足估计的能量和营养需求时，肠外营养（PN）是早产儿和婴儿常规营养护理的一部分。

因此，儿童和成人营养不良的巨大负担以及大量早产推动了对肠外营养配方和产品的需求，从而推动了市场。

欧洲肠外营养市场概况

在德国，有几起与超重问题、肥胖和营养不良有关的案例。根据罗伯特科赫研究所的数据，到 2022 年，大约三分之二的男性和一半以上的女性超重。有活动性肿瘤的患者往往缺乏足够的食物；因此，肠外和肠内营养用于预防或减少进行性体重减轻。德国科学医学会协会表示，患有严重胃肠道缺陷（例如放射性肠炎）的患者可以从肠外营养中受益。在大多数情况下，人工营养可以稳定或增加体重和体脂肪量。

而且，德国幽门螺旋桿菌感染发生率较高，是胃癌发生的重要原因。根据临床微生物学和感染杂誌 (ELSEVIER) 的一项研究 (2020)，幽门螺旋桿菌感染了德国约 25% 的总人口，并引起胃炎，并进一步併发胃腺癌。此外，德国的胃癌发生率很高，这促进了该国的诊断程序。根据国际癌症研究机构的最新资料，德国胃癌的年龄标准化发生率为每10万人中7人，粗率为18.29。上述因素正在推动德国肠外营养市场的发展。

欧洲肠外营养市场收入及 2030 年预测（百万美元）

欧洲肠外营养市场细分

欧洲肠外营养市场根据营养素类型、最终用户和国家进行细分。根据营养素类型，欧洲肠外营养市场分为单剂量胺基酸溶液、肠外脂肪乳、碳水化合物、微量元素、维生素和矿物质。 2022 年，单剂量胺基酸溶液细分市场占据最大市场份额。

依最终用户划分，欧洲肠外营养市场分为医院、诊所等。 2022 年，医院细分市场占据最大的市场份额。

根据国家/地区，欧洲肠外营养市场分为以下几个部分。 2022年，德国在欧洲肠外营养市场占有率中占据主导地位。

ICU Medical Inc、Grifols SA、辉瑞公司、大冢製药有限公司、百特国际公司、B Braun SE、Fresenius Kabi AG、Aculife Healthcare Pvt Ltd 和 Vifor Pharma Management AG 是欧洲肠外营养市场的一些领先参与者。

Malnutrition includes being undernourished, overweight or obese, having inadequate vitamins or minerals, and having a non-communicable disease due to a bad diet. As per World Health Organization (WHO) data, ~1.9 billion adults were overweight or obese, whereas 462 million were underweight in 2021. Additionally, 39 million children under the age of 5 were overweight, 149 million had stunted growth and development as a result of a chronic lack of nutrient-rich food in their diets, and 45 million were wasted (too thin for height). Furthermore, ~45% of deaths among children aged less than 5 are associated with undernutrition. As per the July 2022 data of the United Nations International Children's Emergency Fund (UNICEF), the prevalence of undernourishment reached 9.3% in 2020 from 8.0% in 2019; it further jumped to 9.8% in 2021.

According to a Specialized Nutrition Europe study, ~40% of hospitalized adult patients were malnourished in Europe in 2019. As per a study titled "A multi-centre survey on hospital malnutrition," published in 2021, approximately 11-45% of patients in hospitals and home care settings in England suffered from malnutrition. Nutritional support delivered through parenteral methods, depending on the need, is an important and appropriate way of treating most malnutrition cases.

Preterm birth refers to a baby being born at a significantly early stage, i.e., before the completion of 37 weeks of pregnancy. As per the WHO data published in 2023, ~13.4 million preterm births (more than 1 in 10 births) were reported worldwide in 2020. On average, 12% of babies in low-income countries are born too early, compared to 9% in high-income countries. A large number of premature babies suffer from low weight and undeveloped immunity, which puts their lives at risk. Parenteral nutrition is preferred in preterm infants due to sucking or swallowing difficulties as a complication of an immature birth or due to neuromuscular, heart, or other disorders. When estimated energy and nutritional requirements cannot be safely met by enteral route right after birth, parenteral nutrition (PN) is part of the routine nutrition care for premature neonates and infants.

Thus, the huge burden of malnutrition in children and adults and the high number of preterm births drive the demand for parenteral nutrition formulae and products, which drives the market.

Europe Parenteral Nutrition Market Overview

In Germany, there are several cases related to overweight issues, obesity, and malnutrition. According to the Robert Koch Institute, approximately two-thirds of men and over half of women were overweight in 2022. Nutritional deficiencies lead to unfavorable outcomes and lower quality of life in patients with malignancies. Patients with active tumors often lack sufficient food; hence, parenteral and enteral nutrition is used to prevent or reduce progressive weight loss. According to the Association of the Scientific Medical Societies in Germany, patients with severe gastrointestinal defects, such as radiation enteritis, can benefit from parenteral nutrition. In most cases, artificial nutrition stabilizes or increases body weight and body fat mass.

Moreover, the incidence of H. pylori infection in Germany is high, which is a significant cause of gastric cancer. According to a study (2020) in the Clinical Microbiology and Infection Journal (ELSEVIER), Helicobacter pylori infected ~25% of the total population in Germany and caused gastritis that becomes more complicated with gastric adenocarcinoma. Furthermore, Germany has a significant incidence rate of stomach cancer, which promotes diagnostic procedures in the country. According to the latest data from the International Agency for Research on Cancer, the estimated age-standardized incidence rate for stomach cancer in Germany is 7 per 100,000, and the crude rate is 18.29. The abovementioned factors are driving the parenteral nutrition market in Germany.

Europe Parenteral Nutrition Market Revenue and Forecast to 2030 (US$ Million)

Europe Parenteral Nutrition Market Segmentation

The Europe parenteral nutrition market is segmented based on nutrient type, end user, and country. Based on nutrient type, the Europe parenteral nutrition market is categorized into single dose amino acid solution, parenteral lipid emulsion, carbohydrates, trace elements, and vitamins and minerals. The single dose amino acid solution segment held the largest market share in 2022.

By end user, the Europe parenteral nutrition market is segmented into hospitals, clinics, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Europe parenteral nutrition market is segmented into s. Germany dominated the Europe parenteral nutrition market share in 2022.

ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Aculife Healthcare Pvt Ltd, and Vifor Pharma Management AG are some of the leading players operating in the Europe parenteral nutrition market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Parenteral Nutrition Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Rise in Prevalence of Gastrointestinal Diseases
- 4.1.2 Surge in Cases of Malnutrition and Premature Births
4.2 Market Restraints
- 4.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Parenteral Feeding Systems
4.3 Market Opportunities
- 4.3.1 New Product Developments by Companies
4.4 Future Trends
- 4.4.1 Innovation in Formulations of Nutrition Products
4.5 Impact Analysis

5. Parenteral Nutrition Market - Europe Market Analysis

5.1 Overview
5.2 Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030

6. Europe Parenteral Nutrition Market Analysis - by Nutrient Type

6.1 Overview
6.2 Single Dose Amino Acid Solution
- 6.2.1 Overview
- 6.2.2 Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Parenteral Lipid Emulsion
- 6.3.1 Overview
- 6.3.2 Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Carbohydrates
- 6.4.1 Overview
- 6.4.2 Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Trace Elements
- 6.5.1 Overview
- 6.5.2 Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Vitamins and Minerals
- 6.6.1 Overview
- 6.6.2 Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Parenteral Nutrition Market Analysis - by End User

7.1 Overview
7.2 Hospitals
- 7.2.1 Overview
- 7.2.2 Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Clinics
- 7.3.1 Overview
- 7.3.2 Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Others
- 7.4.1 Overview
- 7.4.2 Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Parenteral Nutrition Market - Country Analysis

8.1 Europe
- 8.1.1 Europe: Parenteral Nutrition Market - Revenue and Forecast Analysis - by Country
  - 8.1.1.1 Germany: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.1.1 Overview
    - 8.1.1.1.2 Germany: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.1.3 Germany: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.1.4 Germany: Parenteral Nutrition Market Breakdown, by End User
  - 8.1.1.2 United Kingdom: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.2.1 Overview
    - 8.1.1.2.2 United Kingdom: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.2.3 United Kingdom: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.2.4 United Kingdom: Parenteral Nutrition Market Breakdown, by End User
  - 8.1.1.3 France: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.3.1 Overview
    - 8.1.1.3.2 France: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.3.3 France: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.3.4 France: Parenteral Nutrition Market Breakdown, by End User
  - 8.1.1.4 Italy: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.4.1 Overview
    - 8.1.1.4.2 Italy: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.4.3 Italy: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.4.4 Italy: Parenteral Nutrition Market Breakdown, by End User
  - 8.1.1.5 Spain: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.5.1 Overview
    - 8.1.1.5.2 Spain: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.5.3 Spain: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.5.4 Spain: Parenteral Nutrition Market Breakdown, by End User
  - 8.1.1.6 Rest of Europe: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.6.1 Overview
    - 8.1.1.6.2 Rest of Europe: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.6.3 Rest of Europe: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.6.4 Rest of Europe: Parenteral Nutrition Market Breakdown, by End User

9. Industry Landscape

9.1 Overview
- 9.1.1 Overview

10. Company Profiles

10.1 ICU Medical Inc
- 10.1.1 Key Facts
- 10.1.2 Business Description
- 10.1.3 Products and Services
- 10.1.4 Financial Overview
- 10.1.5 SWOT Analysis
- 10.1.6 Key Developments
10.2 Grifols SA
- 10.2.1 Key Facts
- 10.2.2 Business Description
- 10.2.3 Products and Services
- 10.2.4 Financial Overview
- 10.2.5 SWOT Analysis
- 10.2.6 Key Developments
10.3 Pfizer Inc
- 10.3.1 Key Facts
- 10.3.2 Business Description
- 10.3.3 Products and Services
- 10.3.4 Financial Overview
- 10.3.5 SWOT Analysis
- 10.3.6 Key Developments
10.4 Otsuka Pharmaceuticals Co Ltd
- 10.4.1 Key Facts
- 10.4.2 Business Description
- 10.4.3 Products and Services
- 10.4.4 Financial Overview
- 10.4.5 SWOT Analysis
- 10.4.6 Key Developments
10.5 Baxter International Inc
- 10.5.1 Key Facts
- 10.5.2 Business Description
- 10.5.3 Products and Services
- 10.5.4 Financial Overview
- 10.5.5 SWOT Analysis
- 10.5.6 Key Developments
10.6 B Braun SE
- 10.6.1 Key Facts
- 10.6.2 Business Description
- 10.6.3 Products and Services
- 10.6.4 Financial Overview
- 10.6.5 SWOT Analysis
- 10.6.6 Key Developments
10.7 Fresenius Kabi AG
- 10.7.1 Key Facts
- 10.7.2 Business Description
- 10.7.3 Products and Services
- 10.7.4 Financial Overview
- 10.7.5 SWOT Analysis
- 10.7.6 Key Developments
10.8 Vifor Pharma Management AG
- 10.8.1 Key Facts
- 10.8.2 Business Description
- 10.8.3 Products and Services
- 10.8.4 Financial Overview
- 10.8.5 SWOT Analysis
- 10.8.6 Key Developments
10.9 Aculife Healthcare Pvt Ltd
- 10.9.1 Key Facts
- 10.9.2 Business Description
- 10.9.3 Products and Services
- 10.9.4 Financial Overview
- 10.9.5 SWOT Analysis
- 10.9.6 Key Developments

11. Appendix

11.1 About The Insight Partners
11.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Parenteral Nutrition Market Segmentation
Table 2. Germany: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 3. Germany: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 4. United Kingdom: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 5. United Kingdom: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 6. France: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 7. France: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 8. Italy: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 9. Italy: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 10. Spain: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 11. Spain: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 12. Rest of Europe: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by Nutrient Type
Table 13. Rest of Europe: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 14. Recent Organic Growth Strategies in the Parenteral Nutrition Market
Table 15. Glossary of Terms, Parenteral Nutrition Market

List Of Figures

Figure 1. Parenteral Nutrition Market Segmentation, By Country
Figure 2. Parenteral Nutrition Market: Key Industry Dynamics
Figure 3. Parenteral Nutrition Market: Impact Analysis of Drivers and Restraints
Figure 4. Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Parenteral Nutrition Market Share (%) - by Nutrient Type (2022 and 2030)
Figure 6. Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Parenteral Nutrition Market Share (%) - by End User (2022 and 2030)
Figure 12. Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Europe: Parenteral Nutrition Market, by Key Country - Revenue (2022) (US$ Million)
Figure 16. Europe: Parenteral Nutrition Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 17. Germany: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 18. United Kingdom: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 19. France: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 20. Italy: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 21. Spain: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)
Figure 22. Rest of Europe: Parenteral Nutrition Market - Revenue and Forecast to 2030(US$ Million)